Why drugs fail: of mice and men revisited.
Takimoto
C H
CH
D000818:Animals; D000970:Antineoplastic Agents / Q000493:pharmacokinetics*; D001682:Biological Availability; D002166:Camptothecin / Q000031:analogs & derivatives* / Q000493:pharmacokinetics*; D004791:Enzyme Inhibitors / Q000493:pharmacokinetics*; D006801:Humans; D051379:Mice; D009369:Neoplasms / Q000378:metabolism*; D014018:Tissue Distribution; D059004:Topoisomerase I Inhibitors
D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D059004:Topoisomerase I Inhibitors; C080125:9-aminocamptothecin; D002166:Camptothecin